Report to the President on reengineering the influenza vaccine production enterprise to meet the challenges of pandemic influenza / Executive Office of the President, President's Council of Advisors on Science and Technology.

Format:

Book

Government document

Author/Creator:

President's Council of Advisors on Science and Technology (U.S.)

Contributor:

United States. Executive Office of the President

Language:

English

Subjects (All):

Influenza--Prevention.

Influenza.

Influenza--United States.

Public health--United States.

Public health.

Emergency management--United States.

Emergency management.

Orphan drugs.

Influenza Vaccines--supply & distribution.

Influenza Vaccines--economics.

Orphan Drug Production.

Influenza, Human--prevention & control.

Mass Vaccination--organization & administration.

Drug Industry--organization & administration.

United States.

Medical Subjects:

Influenza Vaccines--supply & distribution.

Influenza Vaccines--economics.

Orphan Drug Production.

Influenza, Human--prevention & control.

Mass Vaccination--organization & administration.

Drug Industry--organization & administration.

United States.

Physical Description:

1 online resource

Place of Publication:

[Washington, D.C.] : Executive Office of the President of the United States, [2010]

Summary:

This report examines how the United States can more rapidly and reliably produce effective vaccines, at a sufficient scale to protect all of the country's residents, in response to the emergence of pandemic influenza. The report recommends a number of steps that can be taken over the next one to two years to cut several weeks from the time currently needed to produce the first doses of a new vaccine. In addition, the Council identified actions that could greatly improve the reliability of the vaccine manufacturing enterprise over a two to ten year time frame, further shortening the time required to provide vaccine to the entire U.S. population. Several of the recommendations can also improve the country's ability to mount medical counter-measures against a variety of infectious agents. Finally, the successful production of an effective pandemic influenza vaccine requires coordinated actions on the part of government and the private sector; as part of its review, the Council identified ways to better utilize public-private partnerships to optimize the vaccine production enterprise.

Notes:

Title from PDF title page.

"August 2010."

Includes bibliographical references.

Other Format:

Print version: President's Council of Advisors on Science and Technology (U.S.). Report to the President on reengineering the influenza vaccine production enterprise to meet the challenges of pandemic influenza.

OCLC:

664138324